Sign Up to like & get
recommendations!
1
Published in 2022 at "Chemmedchem"
DOI: 10.1002/cmdc.202200262
Abstract: The KV7 potassium channel openers flupirtine and retigabine have been valuable options in the therapy of pain and epilepsy. However, as a result of adverse reactions, both drugs are currently no longer in therapeutic use.…
read more here.
Keywords:
improved oxidation;
carba analogues;
flupirtine retigabine;
oxidation resistance ... See more keywords